Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
AIDS and Behavior
Published in: AIDS and Behavior 3/2019

01-10-2019 | Human Immunodeficiency Virus | Original Paper

Historical and Current Trends in HIV Criminalization in South Carolina: Implications for the Southern HIV Epidemic

Authors: Deanna Cann, Sayward E. Harrison, Shan Qiao

Published in: AIDS and Behavior | Special Issue 3/2019

Login to get access

Abstract

In the 1980s, human immunodeficiency virus (HIV) criminalization laws became widespread across the United States. Today, such laws continue to be used to prosecute people living with HIV for a variety of behaviors though there is limited evidence that doing so curbs HIV transmission. HIV criminalization remains understudied, especially in the Deep South. Therefore, the purpose of this paper was to trace the emergence, maintenance, and enforcement of HIV criminalization laws in South Carolina—a Southern state disproportionately burdened by HIV. Specifically, Nexis Uni and other criminology databases were used to identify HIV-related laws and criminal cases in South Carolina. Results indicate that the state’s criminalization laws have remained nearly unchanged for over 30 years and continue to be used to prosecute individuals, a majority of whom are African–American. Findings support the need to reconsider HIV-related laws and devote more efforts to studying the impact of HIV criminalization on the Southern epidemic.
Footnotes
1
To protect privacy, all names have been changed.
 
Literature
1.
Gostin L. The future of communicable disease control: toward a new concept in public health law. Millbank Quart. 1986;64(1):79–96.
2.
Ford NL, Quam MD. AIDS quarantine: the legal and practical implications. J Legal Med. 1987;8(3):353–96.
3.
Parmet WE. AIDS and quarantine: the revival of an archaic doctrine. Hofstra Law Rev. 1985;14:53–90.
4.
5.
Centers for Disease Control and Prevention. HIV and AIDS–United States, 1981-2000. MMWR. 2001;50(21):430.
6.
Centers for Disease Control and Prevention. Current trends update: acquired immunodeficiency syndrome (AIDS)—United States. MMWR. 1983;32(35):465–7.
7.
Kenny SV. Criminalizing HIV transmission: lessons from history and a model for the future. J Contemp Health Law Policy. 1992;8(1):245–73.
8.
Harsono D, Galletly CL, O’Keefe E, Lazzarini Z. Criminalization of HIV exposure: a review of empirical studies in the United States. AIDS Behav. 2017;21(1):27–50.PubMedPubMedCentral
9.
Mayer KH, Sohn A, Kippax S, Bras M. Addressing HIV criminalization: science confronts ignorance and bias. J Int AIDS Soc. 2018;21(7):e25163.PubMedPubMedCentral
10.
Gostin LO. AIDS pandemic: complacency, injustice, and unfulfilled expectations. Chapel Hill, NC: University of North Carolina Press; 2004.
11.
Smith SF. Proportional mens rea. Am Crim L Rev. 2009;46:127.
12.
The Center for HIV Law & Policy. HIV criminalization in the United States: a sourcebook on state and federal HIV criminal law and practice. New York. NY: The Center for HIV Law & Policy; 2011.
13.
Lehman JS, Carr MH, Nichol AJ, et al. Prevalence and public health implications of state laws that criminalize potential HIV exposure in the United States. AIDS Behav. 2014;18(6):997–1006.PubMedPubMedCentral
14.
Galletly CL, Pinkerton SD. Conflicting messages: how criminal HIV disclosure laws undermine public health efforts to control the spread of HIV. AIDS Behav. 2006;10(5):451–61.PubMed
15.
Gostin LO. Public health strategies for confronting AIDS: legislative and regulatory policy in the United States. JAMA. 1989;261(11):1621–30.PubMed
16.
Collier AC, Coombs RW, Schoenfeld DA, et al. Treatment of human immunodeficiency virus infection with saquinavir, zidovudine, and zalcitabine. N Eng J Med. 1996;334(16):1011–8.
17.
D’Aquila RT, Hughes MD, Johnson VA, et al. Nevirapine, zidovudine, and didanosine compared with zidovudine and didanosine in patients with HIV-1 infection. A randomized, double-blind, placebo-controlled trial. Ann Int Med. 1996;124(12):1019–30.PubMed
18.
Cohen MS, Chen YQ, McCauley M, et al. Antiretroviral therapy for the prevention of HIV-1 transmission. N Engl J Med. 2016;375(9):830–9.PubMedPubMedCentral
19.
Grulich AE, Bavinton BR, Jin F, et al. HIV transmission in male serodiscordant couples in Australia, Thailand and Brazil. 2015; 22nd Conference on Retroviruses and Opportunistic Infections.
20.
21.
White House Office of National AIDS Policy. National HIV/AIDS strategy for the United States. Washington, DC: The White House; 2010.
22.
US Department of Justice. Best practices guide to reform HIV-specific criminal laws to align with scientifically-supported factors. Washington. DC: US Department of Justice Civil Rights Division; 2014.
23.
Wolf LE, Vezina R. Crime and punishment: is there a role for criminal law in HIV prevention policy. Whittier Law Rev. 2003;25:821.
24.
Lichtenstein B, Whetten K, Rubenstein C. “Notify your partners—it’s the law” HIV providers and mandatory disclosure. J Int Assoc Provid AIDS Care. 2014;13(4):372–8.PubMed
25.
Galletly CL, Pinkerton SD, DiFranceisco W. A quantitative study of Michigan’s criminal HIV exposure law. AIDS Care. 2012;24(2):174–9.PubMed
26.
Galletly CL, Glasman LR, Pinkerton SD, DiFranceisco W. New Jersey’s HIV exposure law and the HIV-related attitudes, beliefs, and sexual and seropositive status disclosure behaviors of persons living with HIV. Am J Public Health. 2012;102(11):2135–40.PubMedPubMedCentral
27.
Galletly CL, DiFranceisco W, Pinkerton SD. HIV-positive persons’ awareness and understanding of their state’s criminal HIV disclosure law. AIDS Behav. 2009;13(6):1262.PubMed
28.
Galletly CL, Lazzarini Z. Charges for criminal exposure to HIV and aggravated prostitution filed in the Nashville, Tennessee prosecutorial region 2000–2010. AIDS Behav. 2013;17(8):2624–36.PubMedPubMedCentral
29.
Hoppe T. From sickness to badness: the criminalization of HIV in Michigan. Soc Sci Med. 2014;101:139–47.PubMed
30.
Moberly WH. The ethics of punishment/by Sir Walter Moberly. London: Faber; 1968.
31.
Poteat T, Diouf D, Drame FM, et al. HIV risk among MSM in Senegal: a qualitative rapid assessment of the impact of enforcing laws that criminalize same sex practices. PLoS ONE. 2011;6(12):e28760.PubMedPubMedCentral
32.
Sah P, Fitzpatrick MC, Pandey A, Galvani AP. HIV criminalization exacerbates subpar diagnosis and treatment across the United States: response to the ‘Association of HIV diagnosis rates and laws criminalizing HIV exposure in the United States’. AIDS. 2017;31(17):2437–9.PubMed
33.
Lee SG. Criminal law and HIV testing: empirical analysis of how at-risk individuals respond to the law. Yale J Health Policy Law Ethics. 2014;14(1):194–238.PubMed
34.
Wise DL. Criminal penalties for non-disclosure of HIV-positive status: effects on HIV testing rates and incidence. Proquest unpublished dissertation. 2008.
35.
Burris S, Beletsky L, Burleson J, Case P, Lazzarini Z. Do criminal laws influence HIV risk behavior? An empirical trial. Ariz St Law J. 2007;39:467.
36.
Horvath KJ, Weinmeyer R, Rosser S. Should it be illegal for HIV-positive persons to have unprotected sex without disclosure? An examination of attitudes among US men who have sex with men and the impact of state law. AIDS Care. 2010;22(10):1221–8.PubMedPubMedCentral
37.
Reif S, Pence BW, Hall I, Hu X, Whetten K, Wilson E. HIV diagnoses, prevalence and outcomes in nine southern states. J Comm Health. 2015;40(4):642–51.
38.
39.
40.
41.
Centers for Disease Control and Prevention. Diagnoses of HIV infection in the United States and dependent areas, 2016. HIV Surveill Rep. 2017;28:1–125.
42.
43.
Reif S, Safley D, McAllaster C, Whetten K. State of HIV in the US Deep South. J Comm Health. 2017;42(5):844–53.
44.
45.
Baeten JM, Donnell D, Ndase P, et al. Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. N Eng J Med. 2012;367(5):399–410.
46.
Grant RM, Lama JR, Anderson PL, et al. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Eng J Med. 2010;363(27):2587–99.
47.
Van Damme L, Corneli A, Ahmed K, et al. Preexposure prophylaxis for HIV infection among African women. N Eng J Med. 2012;367(5):411–22.
48.
Del Romero J, Marincovich B, Castilla J, et al. Evaluating the risk of HIV transmission through unprotected orogenital sex. AIDS. 2002;16(9):1296–7.PubMed
49.
Raiteri R, Baussano I, Giobbia M, Fora R, Sinicco A. Lesbian sex and risk of HIV transmission. AIDS. 1998;12(4):450–1.PubMed
50.
51.
Hetey RC, Eberhardt JL. The numbers don’t speak for themselves: racial disparities and the persistence of inequality in the criminal justice system. Curr Dir Psychol Sci. 2018;27(3):183–7.
52.
53.
Green G. Attitudes towards people with HIV: are they as stigmatizing as people with HIV perceive them to be? Soc Sci Med. 1995;41(4):557–68.PubMed
54.
Mumin AA, Gyasi RM, Segbefia AY, Forkuor D, Ganle JK. Internalised and social experiences of HIV-induced stigma and discrimination in urban Ghana. Glob Soc Welf. 2018;5(2):83–93.
55.
Chesney MA, Smith AW. Critical delays in HIV testing and care: the potential role of stigma. Am Behav Sci. 1999;42(7):1162–74.
56.
Goldenberg T, Stephenson R, Bauermeister J. Community stigma, internalized homonegativity, enacted stigma, and HIV testing among young men who have sex with men. J Comm Psychol. 2018;46(4):515–28.
57.
Preston DB, D’Augelli AR, Kassab CD, Starks MT. The relationship of stigma to the sexual risk behavior of rural men who have sex with men. AIDS Educ Prev. 2007;19(3):218–30.PubMed
58.
Urbaeva Z, Warner L. Relationships between HIV testing, knowledge, and stigma among men: reports from Belarus, Moldova, and Ukraine. J HIV/AIDS Soc Serv. 2018;17(1):1–13.
Metadata
Title
Historical and Current Trends in HIV Criminalization in South Carolina: Implications for the Southern HIV Epidemic
Authors
Deanna Cann
Sayward E. Harrison
Shan Qiao
Publication date
01-10-2019
Publisher
Springer US
Published in
AIDS and Behavior / Issue Special Issue 3/2019
Print ISSN: 1090-7165
Electronic ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-019-02599-1

Other articles of this Special Issue 3/2019

AIDS and Behavior 3/2019 Go to the issue

Original Paper

Homonegativity Experienced over the Life Course by Young Black Gay, Bisexual and Other Men Who Have Sex with Men (YB-GBMSM) Living with HIV in Atlanta, Georgia

Original Paper

Characteristics of and Trends in HIV Diagnoses in the Deep South Region of the United States, 2012–2017

Original Paper

Improving the HIV Prevention Landscape to Reduce Disparities for Black MSM in the South

Original Paper

U.S. Centers for Disease Control and Prevention and Health Resources and Services Administration Initiatives to Address Disparate Rates of HIV Infection in the South

Original Paper

PrEP Implementation and Persistence in a County Health Department Setting in Atlanta, GA

Commentary

From Epidemiology to Action: The Case for Addressing Social Determinants of Health to End HIV in the Southern United States
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits